Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation

AIMS: Therapeutic drug monitoring (TDM) can optimize the efficacy of infliximab (IFX) in patients with inflammatory bowel disease (IBD). Because of the delay between blood samples taken at trough and availability of results, dose adjustments can only be carried out at the next infusion, typically 8 ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Clin Pharmacol
Autors principals: Berends, Sophie E., D'Haens, Geert R. A. M., Schaap, Tiny, de Vries, Annick, Rispens, Theo, Bloem, Karien, Mathôt, Ron A. A.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595298/
https://ncbi.nlm.nih.gov/pubmed/30927375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13939
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars